Drugmaker Eli Lilly & Co is announcing a temporary shortage of two of its insulin products. "The 10 mL [millilter] vials of ...

Patients may have trouble finding two different types of insulin products made by Eli Lilly. The company said it's experiencing a shortage of its 10 mL vials of Humalog and Insulin Lispro ...

The Tempo pen is currently compatible with three of Lilly's insulin products, including Humalog and Lyumjev, both insulin lispro-based, and insulin glargine brand Basaglar. "Despite technological ...

Lilly's arch-rival in the diabetes category Novo Nordisk is working on its own glucose-sending insulin platform, acquired via its $800 million acquisition of UK biotech Ziylo in 2018.